Protective effect of atorvastatin on radiation-induced vascular endothelial cell injury in vitro

Journal of Radiation Research

Volumn 51, Issue 5, 2010, Pages 527-533

  Ran, Xin Ze ^a   Ran, Xi ^a   Zong, Zhao Wen ^a   Liu, Deng Qun ^a   Xiang, Gui Ming ^a   Su, Yong Ping ^a   Zheng, Huai En ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; IONIZING RADIATION; IRRADIATION; PROTEINS; RADIATION PROTECTION; RADIOTHERAPY;

ATORVASTATIN; CELL INJURY; CELL-BE; CELL/B.E; CELL/BE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; PROTECTIVE EFFECTS; RADIATION-INDUCED; THROMBOMODULIN; VASCULAR ENDOTHELIAL CELLS;

CELL DEATH;

EID: 77958560783     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.09119     Document Type: Article

References (19)

1. Juncos LI, et al (1997) Abnormal endothelium-dependent responses in early radiation nephropathy. Hypertension 30: 672-676.
2. Wang J, et al (2002) Deficiency of microvascular thrombo-modulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am J Pathol 160: 2063-2072.
3. Wang J, et al (2007) Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol 13: 3047-3055.
4. Wang J, et al (2007) Simvastatin ameliorates radiation enter-opathy development after localized, fractionated irradiation by a protein C-independent mechanism. Int J Radiat Oncol Biol Phys 68: 1483-1490.
5. Haydont V, et al (2007) Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection. Int J Radiat Oncol Biol Phys 68: 1471-1482.
6. Takatsuka H, et al (2002) Effects of total body irradiation on the vascular endothelium. Clin Transplant 16: 374-377.
7. Paris F, et al (2001) Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297.
8. Istvan ES and Deisenhofer J (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292: 1160- 1164.
9. Bonetti PO, et al (2003) Statin effects beyond lipid lowering- are they clinically relevant? Eur Heart J 24: 225-248.
10. Wierzbicki AS, Poston R and Ferro A (2003) The lipid and non-lipid effects of statins. Pharmacol Ther 99: 95-112.
11. Liao JK (2005) Clinical implications for statin pleiotropy. Curr Opin Lipidol 16: 624-629.
12. Gaugler MH, et al (2005) Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat Res 163: 479-487.
13. Williams JP, et al (2004) Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiat Res 161: 560-567.
14. Sadler JE (1997) Thrombomodulin structure and function. Thromb Haemost 78: 392-395.
15. Grey ST and Hancock WW (1996) A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J Immunol 156: 2256-2263.
16. Van-de-Wouwer M, Collen D and Conway EM (2004) Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 24: 1374-1383.
17. Russo MW and Jacobson IM (2004) How to use statins in patients with chronic liver disease. Cleve Clin J Med 71: 58- 62.
18. Oda H and Keane WF (1999) Recent advances in stations and the kidney. Kidney Int 71: S2-S5.
19. Gervaz P, Morel P and Vozenin-Brotons MC (2009) Molecular aspects of intestinal radiation-induced fibrosis. Curr Mol Med 9: 273-280.